25OH-vitamin D3 levels in obesity and metabolic syndrome—unaltered in young and not correlated to carotid IMT in all ages

Current Pharmaceutical Design

Volumn 21, Issue 17, 2015, Pages 2243-2249

  Mangge, Harald ^a,b   Zelzer, Sieglinde ^a   Meinitzer, Andreas ^a   Stelzer, Ingeborg ^a   Schnedl, Wolfgang J ^c   Weghuber, Daniel ^d   Fuchs, Dietmar ^e   Postolache, Teodor T ^f   Aigner, Elmar ^d   Datz, Christian ^d,g   Reininghaus, Eva Z ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b BIOTECHMED GRAZ   (Austria)

^c General Practice for Internal Medicine   (Austria)

^d PARACELSUS MEDICAL UNIVERSITY   (Austria)

^e INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^f UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^g MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Adults; Juveniles; Metabolic syndrome; Preatherosclerosis; Vitamin D

Indexed keywords

C REACTIVE PROTEIN; CALCIFEDIOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; KYNURENINE; LEPTIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; TRYPTOPHAN; URIC ACID;

ADOLESCENT; ADULT; AGED; ANTHROPOMETRY; ARTERIAL WALL THICKNESS; ARTICLE; CHILD; CONTROLLED STUDY; GLUCOSE METABOLISM; HOMEOSTATIC MODEL ASSESSMENT INSULIN RESISTANCE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; OBESITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; VITAMIN BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST TO HEIGHT RATIO; WEIGHT CONTROL; AGING; BLOOD; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; MIDDLE AGED; PATHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGING; CALCIFEDIOL; CAROTID INTIMA-MEDIA THICKNESS; CHILD; CROSS-SECTIONAL STUDIES; HUMANS; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84929493306     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612821666150105160931     Document Type: Article

References (33)

1. Mangge H, Almer G, Truschnig-Wilders M, Schmidt A, Gasser R, Fuchs D. Inflammation, adiponectin, obesity and cardiovascular risk. Curr Med Chem 2010; 17: 4511-20.
2. Valtuena J, Gonzalez-Gross M, Huybrechts I, et al. Factors associated with vitamin D deficiency in European adolescents: the HELENA study. J Nutritional Sci Vitaminol 2013; 59: 161-71.
3. Mangge H, Weghuber D, Prassl R, et al. The Role of Vitamin D in Atherosclerosis Inflammation Revisited: More a Bystander than a Player? Curr Vascular Pharmacol 2013.
4. Makariou S, Liberopoulos E, Florentin M, et al. The relationship of vitamin D with non-traditional risk factors for cardiovascular disease in subjects with metabolic syndrome. Archives Med Sci: AMS 2012; 8: 437-43.
5. Dasarathy J, Periyalwar P, Allampati S, et al. Hypovitaminosis D is associated with increased whole body fat mass and greater severity of non-alcoholic fatty liver disease. Liver international : official journal of the International Association for the Study of the Liver 2013.
6. Kazlauskaite R, Powell LH, Mandapakala C, Cursio JF, Avery EF, Calvin J. Vitamin D is associated with atheroprotective highdensity lipoprotein profile in postmenopausal women. J Clin Lipidol 2010; 4: 113-9.
7. Kunutsor SK, Apekey TA, Steur M. Vitamin D and risk of future hypertension: meta-analysis of 283, 537 participants. Eur J Epidemiol 2013; 28: 205-21.
8. The Lancet Diabetes E. Vitamin D: chasing a myth? The lancet Diabetes & endocrinology 2014; 2: 1.
9. Amin A, Minaee S, Chitsazan M, Naderi N, Taghavi S, Ardeshiri M. Can vitamin D supplementation improve the severity of congestive heart failure? Congest Heart Fail 2013; 19: E22-8.
10. Gotsman I, Shauer A, Zwas DR, et al. Vitamin D deficiency is a predictor of reduced survival in patients with heart failure; vitamin D supplementation improves outcome. Eur J Heart Failure 2012; 14: 357-66.
11. Lim GB. Heart failure: Study sheds light on importance of vitamin D in patients with HF. Nature Rev Cardiol 2012; 9: 188.
12. Witham MD. Vitamin D in chronic heart failure. Curr Heart Failure Reports 2011; 8: 123-30.
13. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. Bmj 2000; 320: 1240-3.
14. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new worldwide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006; 23: 469-80.
15. Zimmet P, KG MMA, Serrano Rios M. A new international diabetes federation worldwide definition of the metabolic syndrome: the rationale and the results.. Rev Esp Cardiol 2005; 58: 1371-6.
16. Tepper S, Shahar DR, Geva D, et al. Identifying the threshold for vitamin D insufficiency in relation to cardiometabolic markers. Nutrition, metabolism, and cardiovascular diseases : NMCD 2013.
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-9.
18. Widner B, Werner ER, Schennach H, Wachter H, Fuchs D. Simultaneous measurement of serum tryptophan and kynurenine by HPLC. Clin Chem 1997; 43: 2424-6.
19. Reid IR, Bolland MJ, Grey A. Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis. Lancet 2014; 383: 146-55.
20. Stoffman N, Gordon CM. Vitamin D and adolescents: what do we know? Curr Opinion Pediatrics 2009; 21: 465-71.
21. Sergeev IN, Song Q. High vitamin D and calcium intakes reduce diet-induced obesity in mice by increasing adipose tissue apoptosis. Molecular Nutrition Food Res 2014.
22. Sokol SI, Srinivas V, Crandall JP, et al. The effects of vitamin D repletion on endothelial function and inflammation in patients with coronary artery disease. Vascular Med 2012; 17: 394-404.
23. Kox M, van den Berg MJ, van der Hoeven JG, Wielders JP, van der Ven AJ, Pickkers P. Vitamin D status is not associated with inflammatory cytokine levels during experimental human endotoxaemia. Clin Exp Immunol 2013; 171: 231-6.
24. Deleskog A, Piksasova O, Silveira A, et al. Serum 25-hydroxyvitamin D concentration in subclinical carotid atherosclerosis. Arteriosclerosis, Thrombosis, Vascular Biol 2013; 33: 2633-8.
25. Lavie CJ, Lee JH, Milani RV. Vitamin D and cardiovascular disease will it live up to its hype? J Am College Cardiol 2011; 58: 1547-56.
26. Blondon M, Sachs M, Hoofnagle AN, et al. 25-Hydroxyvitamin D and parathyroid hormone are not associated with carotid intimamedia thickness or plaque in the multi-ethnic study of atherosclerosis. Arterioscler Thromb Vasc Biol 2013; 33: 2639-45.
27. Strawbridge RJ, Deleskog A, McLeod O, et al. A serum 25- hydroxyvitamin D concentration-associated genetic variant in DHCR7 interacts with type 2 diabetes status to influence subclinical atherosclerosis (measured by carotid intima-media thickness). Diabetologia 2014; 57: 1159-72.
28. Codoner-Franch P, Tavarez-Alonso S, Simo-Jorda R, Laporta- Martin P, Carratala-Calvo A, Alonso-Iglesias E. Vitamin D status is linked to biomarkers of oxidative stress, inflammation, and endothelial activation in obese children. J Pediatrics 2012; 161: 848-54.
29. Mangge H, Summers KL, Meinitzer A, et al. Obesity-related dysregulation of the Tryptophan-Kynurenine metabolism: Role of age and parameters of the metabolic syndrome. Obesity 2014; 22: 195-201.
30. Saedisomeolia A, Taheri E, Djalali M, Moghadam AM, Qorbani M. Association between serum level of vitamin D and lipid profiles in type 2 diabetic patients in Iran. J Diabetes Metabolic Disorders 2014; 13: 7.
31. Binkley N, Krueger D, Cowgill CS, et al. Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization. J Clin Endocrinol Metabol 2004; 89: 3152-7.
32. Fraser WD, Milan AM. Vitamin D assays: past and present debates, difficulties, and developments. Calcified Tissue Int 2013; 92: 118-27.
33. Raitakari OT, Juonala M, Ronnemaa T, et al. Cohort profile: the cardiovascular risk in Young Finns Study. Int J Epidemiol 2008; 37: 1220-6.